Browse SEC61A1

Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Endoplasmic reticulum membrane Multi-pass membrane protein Note=Localizes exclusively in granular structures in the endoplasmic reticulum (ER).
Domain PF10559 Plug domain of Sec61p
PF00344 SecY translocase
Function

Plays a crucial role in the insertion of secretory and membrane polypeptides into the ER (PubMed:28782633). Required for assembly of membrane and secretory proteins. Tightly associated with membrane-bound ribosomes, either directly or through adapter proteins. Plays a role in pronephric kidney tubule development (By similarity).

> Gene Ontology
 
Biological Process GO:0006612 protein targeting to membrane
GO:0006613 cotranslational protein targeting to membrane
GO:0006614 SRP-dependent cotranslational protein targeting to membrane
GO:0006620 posttranslational protein targeting to membrane
GO:0006986 response to unfolded protein
GO:0007029 endoplasmic reticulum organization
GO:0016049 cell growth
GO:0030968 endoplasmic reticulum unfolded protein response
GO:0034341 response to interferon-gamma
GO:0034620 cellular response to unfolded protein
GO:0034976 response to endoplasmic reticulum stress
GO:0035966 response to topologically incorrect protein
GO:0035967 cellular response to topologically incorrect protein
GO:0036498 IRE1-mediated unfolded protein response
GO:0045047 protein targeting to ER
GO:0070972 protein localization to endoplasmic reticulum
GO:0072599 establishment of protein localization to endoplasmic reticulum
GO:0072657 protein localization to membrane
GO:0090150 establishment of protein localization to membrane
Molecular Function GO:0043021 ribonucleoprotein complex binding
GO:0043022 ribosome binding
Cellular Component GO:0005791 rough endoplasmic reticulum
GO:0030176 integral component of endoplasmic reticulum membrane
GO:0031227 intrinsic component of endoplasmic reticulum membrane
> KEGG and Reactome Pathway
 
KEGG hsa03060 Protein export
hsa04141 Protein processing in endoplasmic reticulum
hsa04145 Phagosome
Reactome R-HSA-1280218: Adaptive Immune System
R-HSA-1236975: Antigen processing-Cross presentation
R-HSA-983169: Class I MHC mediated antigen processing & presentation
R-HSA-1236974: ER-Phagosome pathway
R-HSA-74160: Gene Expression
R-HSA-381070: IRE1alpha activates chaperones
R-HSA-168256: Immune System
R-HSA-392499: Metabolism of proteins
R-HSA-1799339: SRP-dependent cotranslational protein targeting to membrane
R-HSA-72766: Translation
R-HSA-381119: Unfolded Protein Response (UPR)
R-HSA-381038: XBP1(S) activates chaperone genes
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between SEC61A1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of SEC61A1 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NS NA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NS NA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR Second most enriched score: 0.93 Sensitive to T cell-mediated killing
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NS NA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NS NA/NS
24476824shRNAmelanomaB16Primary screen NA/NS NA/NS
24476824shRNAmelanomaB16Secondary screen NA/NS NA/NS
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of SEC61A1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.140.453
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)650.0680.983
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.2910.903
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.2690.481
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.1660.94
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.4030.89
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.0620.907
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 1511-0.1370.951
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.2650.917
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 480.1720.94
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 280.4180.904
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 682300.1310.0198
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of SEC61A1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 27733.703.70.27
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 27593.703.70.314
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21170001
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13110001
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 91606.2-6.21
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59011.1-11.11
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38270001
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22130001
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of SEC61A1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of SEC61A1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by SEC61A1.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of SEC61A1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of SEC61A1 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between SEC61A1 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolSEC61A1
NameSec61 translocon alpha 1 subunit
Aliases Sec61 alpha 1 subunit (S. cerevisiae); HSEC61; SEC61; SEC61A; Sec61 alpha 1 subunit; Sec61 alpha-1; protein ......
Chromosomal Location3q21.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting SEC61A1 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.